WASHINGTON, DC… The HIV+Hepatitis Policy Institute (HIV+Hep) and American Autoimmune Related Diseases Association (AARDA), in collaboration with 122 other patient and provider organizations, delivered a sign-on letter to U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra that urges HHS and the Biden administration to enact policies and protections that improve prescription drug affordability for the American people.
Biden budget proposes increased funding for ending HIV
Washington DC… In President Biden’s first preliminary budget that was released today, he is proposing to continue to ramp up efforts to end HIV in the United States with an increase of $267 million for domestic HIV testing, prevention, and treatment programs as part of the Ending the HIV Epidemic Initiative.
Biden administration pulls last-minute Trump Medicare drug demo plan
Washington DC… In a victory for patients who depend on Medicare Part D for their medications, the Biden administration has pulled a demonstration project that would have allowed participating Medicare plans in 2022 to not cover all drugs in certain classes and only one drug per class in all others. The proposal that was pulled was announced literally in the final hours of the Trump administration.
Last-minute Trump move to reduce Medicare drug coverage must be reversed
Washington DC… In the final hours of the Trump administration, Seema Verma, former administrator of the Centers for Medicare and Medicaid Services (CMS), announced a Medicare Part D demonstration project…
HIV+Hep welcomes release of HIV national strategic plan
Washington DC… The HIV+Hepatitis Policy Institute applauds the release of the HIV National Strategic Plan: A Roadmap to End the Epidemic by the U.S. Department of Health and Human Services…